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ABSTRACT The utility of a two-photon optical ﬁber ﬂuorescence probe (TPOFF) for sensing and quantifying tumor ﬂuorescent
signals was tested in vivo. Xenograft tumors were developed in athymic mice using MCA207 cells expressing green ﬂuorescent
protein (GFP). The TPOFF probe was able to detect ex vivo ﬂuorescence from excised tumors containing as little as 0.3% GFP-
expressing cells. TPOFF results were similar to both ﬂow-cytometric analysis of tumor cells after isolation and suspension, and
ﬂuorescence determined by microscope images of cryosectioned tumors. TPOFF was then used to measure GFP ﬂuorescence
from tumors in live mice. The ﬁber probe detected ﬂuorescently-labeled Herceptin antibody targeted to HER2-expressing
tumors in severe combined immunodeﬁcient mice. Dendrimer nanoparticles targeted by folic acid and having 6-TAMRA as
a ﬂuorescent probe were also used to label KB cell tumors in vivo. The ﬁber probe documented a fourfold increase in tumor
ﬂuorescence in animals that received the targeted dendrimer. These results suggest TPOFF can be used as a minimally
invasive system for identifying tumor markers and monitoring drug therapy.
INTRODUCTION
The development of noninvasive measures to identify cancer
signatures, monitor drug delivery, and evaluate drug-induced
effects in tumors has been a goal for enhancing cancer
treatment (Nicolette and Miller, 2003). As mechanisms
related to tumor development are identiﬁed, signatures of
these pathways may also have importance in selecting
therapeutics. Because the therapeutic index of any cancer
drug is partly dependent on the local concentration and
duration of exposure to the drug in the tumor (Lankelma,
2002), monitoring the spatial and temporal distribution of
cancer drugs within tumors may allow for more effective and
precise dosing (Eichler and Muller, 1998). Therefore, there
are several reasons why it is important to develop means for
in vivo tumor analysis.
One method proposed for tumor analysis in vivo involves
the use of ﬂuorescent probes (Weissleder and Ntziachristos,
2003). This approach has the advantage of being more
biocompatible than radiation or chemical analysis, and
builds on the wide base of technology developed for in
vitro analysis using ﬂow cytometry and histochemical
staining. However, the use of ﬂuorescent probes for tumor
analysis in vivo has technical problems. The most signiﬁcant
issue is the light absorbing and scattering properties of
tissues that make it difﬁcult to perform noninvasive
ﬂuorescence analysis by spectroscopic techniques (Gan
and Gu, 2000; Li et al., 1998; Sefkow et al., 2001; Svanberg,
2002). Although tissue tends to absorb light at ultraviolet-
visible wavelengths mainly below 600 nm, scattering still
occurs at red and near infrared regions, and other molecules,
such as NAD, collagen, and elastin, cause autoﬂuorescence
that can interfere with signals (Andersson et al., 1997; Pitts
et al., 2001; Svanberg, 2002). Thus, regardless of their
wavelength, ﬂuorescent signals from tissues can be retrieved
only within several millimeters of a surface. This limits the
use of ﬂuorescent markers for most internal tumors, and
makes quantitative analysis particularly difﬁcult. Although
localized ﬂuorescence from organs has been visualized by
whole-body imaging (Mitsiades et al., 2003), such analysis is
not quantitative and may require large amounts of ﬂuores-
cent signals for penetration through tissue barriers.
A ﬁber optic probe inserted into a tumor through a thin
(27-gauge or higher) needle could provide a solution for the
delivery and retrieval of light in vivo. Optical ﬁber-based
detection would be minimally invasive since it would not
require tissue excision or isolation of cells. The probe could
also be inserted using imaging techniques to ensure precise
localization within a suspected tissue site. Fiber optic
biosensors have previously been employed for in situ
quantitation of ﬂuorescent chemicals or biochemical end
products (Abel et al., 1996; Baker et al., 1999; Cullum et al.,
2000; Mourant et al., 1999; Mulchandani et al., 1999; Tan
et al., 1992; Vo-Dinh et al., 1991). However, these methods
were based largely on one-photon ﬂuorescence detection.
Two-photon ﬂuorescence detection has a number of ad-
vantages over a system based on one-photon ﬂuorescence
detection. Two-photon ﬂuorescence detection has a spatial
resolution of only a few microns owing to its localized
nonlinear excitation nature. Two-photon ﬂuorescence de-
tection also allows a broad range of ﬂuorochromes to be
excited with a single laser, allowing one to simultaneously
measure multiple emitters reporting different analyses (e.g.,
the presence of a tumor marker and drug). In addition,
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two-photon systems employ near-infrared light for excita-
tion, whichminimizes tissue damage, photobleaching, and in-
trinsic tissue ﬂuorescence. Finally, since the wavelength of
the emitted light is signiﬁcantly shorter than the excitation
wavelength, the emission can be easily ﬁltered and separated
to obtain a high signal-to-noise ratio.
Although two-photon absorption excitation has been
widely applied to microscopic imaging (Denk et al., 1990;
Squirrell et al., 1999) and recently to endoscopy based on
gradient-index lenses (Jung and Schnitzer, 2003), its use for
in vivo biosensing with a ﬂexible ﬁber optic system has not
been explored. We have recently reported the development
of a two-photon optical ﬁber ﬂuorescence (TPOFF) system
using a single-mode ﬁber to deliver femtosecond laser pulses
for excitation and to collect emitted ﬂuorescence from cell
pellets back through the same ﬁber (Ye et al., 2002).
Whereas other optical systems require separate devices for
excitation and collection of ﬂuorescence signals (Lago et al.,
1995), this unique conﬁguration using a single optical ﬁber
for both two-photon excitation and collection provides a very
compact system for making minimally invasive and highly
spatially localized ﬂuorescence measurements in vivo. In the
present work, we report in vivo ﬂuorescence detection in
tumors possessing varying proportions of green ﬂuorescent
protein (GFP)-expressing MCA207 mouse sarcoma cells,
based on the TPOFF probe. In addition, we demonstrate the
utility of TPOFF to detect a targeted antibody in MCA207
tumors and a targeted ﬂuorescent nanoprobe in human
squamous cell (KB) tumors in mice, documenting the
presence of two different tumor markers.
MATERIALS AND METHODS
Materials
KB cells (a human epidermoid carcinoma cell line) were obtained from
ATCC (Rockville, MD). Kevin McDonough at the University of Michigan
kindly provided green ﬂuorescent protein (GFP) - and HER2-transfected
mouse sarcoma MCA207 cell lines. Herceptin was from the University of
Michigan Hospital Pharmacy. Phosphate-buffered saline (PBS), Hanks
Balanced Salt Solution (HBSS) and other cell culture reagents were from
Gibco BRL (Grand Island, NY). 6-carboxytetramethylrhodamine succini-
midyl ester (6TAMRA, 6T) was purchased fromMolecular Probes (Eugene,
OR). 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide HCl (DPE) was
from Pierce (Rockford, IL). The G5-PAMAM dendrimer was synthesized
and characterized as described (Tomalia et al., 1985) (M ¼ 26,000; 110
surface NH2 groups). The athymic nu/nu and SCID mice were purchased
from Charles River (Richmond, IN). All other chemicals were from Sigma-
Aldrich (St. Louis, MO).
Synthesis of Herceptin-FI conjugate
Herceptin antibody-FI conjugate (HN-FI) was synthesized using standard
protocols. Brieﬂy, a dimethylsulfoxide (DMSO) solution of FI in 40-fold
molar excess was added to a PBS solution of the antibody (5 mg/ml) and
incubated in dark at room temperature. The reaction was then quenched with
ammonium chloride (50 mM) and the conjugate was puriﬁed by gel ﬁltration
on a G-25 Sephadex PD-10 column (Pharmacia, Kirkland, Canada). The
conjugate fractions were collected and concentrated.
Synthesis of G5-6T and G5-6T-folic acid (FA)
dendrimer conjugates
2.4 mmol of G5 suspended in 1 M NaHCO3 buffer, pH 8, was slowly stirred
with 8.2 mmol of 6T for 20 h at 4C. The mixture was dialyzed in PBS and
water in their order, ultraﬁltered, and lyophilized to obtain the product
G5-6T. For conjugation of FA to G5-6T, 4.3 mmol of FA was initially acti-
vated by reaction with 6.5 mmol of DPE in dimethylformamide/DMSO (3:1)
for 1.5 h, under N2. The mixture was then stirred with 0.73 mmol of G5-6T
for 2.5 days at 4C, dialyzed as given above, and the product (G5-6T-FA)
was lyophilized. The remaining surface NH2 groups of G5-6T and G5-6T-
FA were acetylated by reacting 0.73 mmol of the synthesized products in
two successive steps of 1 h duration with 79.5 mmol of acetic anhydride and
103 mmol of ethylene triamine. This mixture was stirred for 20 h, dialyzed,
and ultraﬁltered as given above. The product was further puriﬁed by size
exclusion chromatography, lyophilized, and stored at 20C. Character-
ization of the product by 1H-NMR and ultraviolet-visible spectroscopy gave
the respective numbers of 6T and FA molecules per dendrimer to be 3 and 4.
TPOFF analysis of G5-6T dendrimers with and without FA showed that the
optical spectra of these compounds had a maximum emission at 560 nm
similar to free 6T.
Tissue culture
MCA207 cells were maintained in DMEM media supplemented with 10%
heat-inactivated fetal calf serum (FCS), 2 mm L-glutamine, 100 U/ml
penicillin and 100 mg/ml streptomycin, under 5% CO2. KB cells were
maintained in FA-free Roswell Park Memorial Institute-1640, and under the
other conditions given above.
Animal model
MCA207 and KB cell xenograft tumors were developed in 7-week-old
female athymic nu/nu or SCID mice by subcutaneous inoculation of 5 3
106 cells in the left and right ﬂank area. The cells were rinsed and injected as
a 0.1-ml suspension using sterile PBS. Mice were housed under sterile
conditions and the tumors were allowed to reach ;0.7–0.8 cm in diameter
before analysis. At the end of the study, the mice were anesthetized with
isoﬂurane and the tumors were excised for analysis. The control and GFP-
transfected MCA207 tumors were excised and divided into three portions for
ﬂow cytometry, imaging, and TPOFF analysis.
Flow cytometric and microscopic analysis
Fresh tumor samples were suspended in Hanks’ balanced salt solution
(HBSS), crushed, and digested with 1 mg/ml type IV-collagenase for 2 h at
room temperature. The digested tissue was passed through a 70-micron
ﬁlter, rinsed with HBSS and ﬁxed in 2% paraformaldehyde. The ﬁxed cells
were rinsed and suspended in PBS containing 0.1% bovine serum albumin
for ﬂow-cytometric analysis. For microscopic imaging, the tissue was
chilled in Optimum Cutting Temperature solution (Sakura Finetechnical,
Tokyo, Japan) by immersing in methylbutane/dry ice mixture (50C), and
stored at 80C for cryosectioning. Fifteen-micron sections were thawed,
hydrated, and ﬁxed with paraformaldehyde and rinsed. The sections were
stained with 4#,6-diamidino-2-phenylindole for 10 min, rinsed, placed on
0.17-m coverslips and mounted with ProLong (Molecular Probes, Eugene,
OR). The images were taken on a Nikon Multiphot (Tokyo, Japan) inverted
microscope using a Hamamatsu camera (Shizuoka, Japan). The pixel
intensities of the images were measured with NIH Image software
(Washington, DC).
TPOFF measurement through optic ﬁber
TPOFF detection was performed as previously described (Ye, et al., 2002).
Brieﬂy, ultrashort pulses from a Ti:sapphire laser (80-fs pulses at 830 nm)
were coupled into a single-mode optical ﬁber. The ﬁber was inserted into the
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tissue through a 27-gauge needle, with the ﬁber tip extending to the proximal
edge of the needle opening. The two-photon excited ﬂuorescence was
collected back through the same ﬁber. The ﬂuorescence signal was separated
from the excitation beam with a dichroic mirror, and further ﬁltered with
a short-pass ﬁlter (E600SP, Chroma, McHenry, IL) and a spectrometer
(250is/sm, Chromex, Albuquerque, NM), then detected with a photon-
counting photomultiplier tube. TPOFF counts were taken in multiple
internal regions of the tumor, with the tip of the needle cleaned by bath-
sonication between each run, and the readings were taken for ;60 s in each
region at the rate of one reading per second. TPOFF counts were taken in
live mice by anesthetizing the mice by isoﬂurane inhalation for 1 min, and
inserting the needle into the tumor through the skin.
Statistical signiﬁcance of differences among groups was analyzed by the
Student-Newman-Keuls test, with signiﬁcance calculated at P , 0.05 by
t-test.
RESULTS
Analysis of tumor ﬂuorescence by ﬂow cytometry
and microscopic imaging
MCA207 tumor cells were injected subcutaneously to form
xenograft tumors in nu/nu mice. The tumors reached an
average size of 0.7-cm diameter 10 days after injection of
5 3 106 cells. To obtain tumors with variable GFP content,
mice were injected with different proportions of control and
GFP-expressing cell lines ranging from 0.3% to 100% GFP-
positive cells, while keeping the total number of injected
cells the same. The proportion of GFP-positive cells in the
tumor was veriﬁed by ﬂow cytometry before injection, and
microscopic analysis and ﬂow cytometry of cells isolated
from the tumor. The overall population of ﬂuorescent cells
was proportional to the percentage of GFP-positive cells
administered (Fig. 1 A). The GFP ﬂuorescence in the tumor
interior was somewhat heterogeneous, as demonstrated by
microscopic analysis of tissue cryosections (Fig. 1 B).
TPOFF ﬂuorescence identiﬁcation and
quantiﬁcation ex vivo in isolated tumors
TPOFF measurements were performed ex vivo in multiple
internal regions of the various GFP-expressing tumors
isolated by resection (Fig. 2 A). The probe was inserted into
different portions of the tumors through a 27-gauge needle
and readings were taken continuously during the inser-
tion through the tumor. The results are the average of ﬁve
readings taken in different parts of each tumor, and
demonstrate a dose-dependent increase in ﬂuorescence in
tumors developed with increasing proportions of GFP cells.
Readings for different regions of each tumor varied with
a standard deviation of 10–20%, as expected given the
heterogeneous distribution of ﬂuorescence observed in the
microscopic images of tissue sections. A comparison of
the mean TPOFF readings with ﬂow cytometric values from
isolated cells, as well as with microscopic image pixel
intensity is shown in Fig. 2 B. As the ﬁber probe excitation
area is 4 m in diameter, pixel intensity analysis was taken at
a cross-section width of 10 pixels (;4 m), to provide a direct
comparison. The correlation of the average TPOFF reading
versus percent GFP by ﬂow cytometry of isolated cells was
very close, giving an R2 value of 0.99. A similar correlation
was observed between ﬂow cytometry and microscopic pixel
intensity analysis with an R2 value of 0.98.
TPOFF tumor ﬂuorescence identiﬁcation and
quantiﬁcation in vivo
TPOFF measurements were then taken in vivo in tumors in
live mice. Tumors ranged from 0 to 50% GFP-expressing
cells as veriﬁed by ﬂow cytometry performed on an aliquot
of cells before implantation. The probe was inserted into the
tumor through the skin. A progressive increase in ﬂuores-
cence was observed with increasing percentages of GFP-
expressing cells in the tumor (Fig. 3).
Identiﬁcation and quantiﬁcation of targeted
tumor ﬂuorescence by TPOFF
The utility of TPOFF probe for quantifying tumor ﬂuores-
cence was tested in HER2-expressing MCA207 tumors
FIGURE 1 Fluorescent microscopic images of nu/nu mice tumors developed with 0–100% GFP-transfected cells. (A) Isolated cells; (B) cryosections.
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using systemically administered ﬂuorescent labeled antibody
HN-FI as the targeting agent (Molina et al., 2001). Free FI
or control antibody administered intravenously failed to
associate with either control or HER2-expressing tumors.
However, signiﬁcantly higher HN-FI ﬂuorescence was
detected in the HER2-expressing tumor as compared to
control tumors at 4 h, as demonstrated by both TPOFF probe
and ﬂow cytometry, in isolated tumors ex vivo (Fig. 4) and in
live mice in vivo (Fig. 5). Although the TPOFF data showed
some accumulation of HN-FI in the control tumor, ﬂow
cytometric analysis of isolated cells failed to show any
corresponding increase in ﬂuorescence (compare Fig. 5, A
and B). This is probably due to the TPOFF detection of
bound HN-FI in tumor macrophages or other blood
components, which are separated from tumor cells when
selected for ﬂow cytometric analysis.
G5 dendrimers with FI and FA as the respective detecting
and targeting agents (G5-FI-FA) have been shown to target
and internalize into KB cells in vitro due to binding to the
high-afﬁnity folate receptor, and show saturable receptor
binding kinetics obtained by ﬂow cytometry and TPOFF
(Quintana et al., 2002; Ye et al., 2002). KB cell tumors in
SCID mice that expressed high-afﬁnity FA-receptor (FAR)
were targeted by folate-conjugated G5 dendrimers bearing
the ﬂuorescent dye 6-TAMRA (6T). The TPOFF counts
obtained for the tumors were converted to pmols of
dendrimer from standard curves of TPOFF readings
generated for different dendrimer concentrations. As shown
in Fig. 6 A, there was an eightfold increase in the levels of
G5-6T-FA in KB cell tumors as compared to the nontargeted
G5-6T dendrimer, whereas the liver and spleen failed to
show any uptake of the dendrimers. There was a threefold
increase in the ﬂuorescence of G5-6T-FA dendrimers in
FAR-positive KB cell tumors as compared to the FAR-
negative MCA207 tumors (Fig. 6 B).
As shown in Fig. 6, in the FAR-positive KB cells, G5-6T-
FA reached average levels of;2.5 mM. As there are 3–4 FA
per dendrimer, the average intracellular FA equivalent is
7.5–10 mM. These values compare well with radioactive FA
binding studies that show KB cell binds ;1–10 mM of FA
in the presence of extracellular concentrations of 5–100 nM
of free FA (personal communication). In vitro TPOFF data
using ﬂuorescein isothiocyanate-conjugated dendrimer
FIGURE 2 TPOFF counts of isolated tumors. TPOFF counts were taken
in distinct internal regions of each tumor by repeated insertion of the probe
for 60–70 s. The needle was vertically moved into the tumor and one reading
was recorded per second. (A) Five individual tracings of TPOFF counts from
three tumors developed with 0, 30, and 100% GFP cells. Similar data were
obtained in four different sets of tumors. (B) Comparison of TPOFF counts
to ﬂow cytometric and microscopic data. The values are expressed as
percentage of the maximum ﬂuorescence obtained for each method. For each
method there is a linear relationship between average counts and percent
GFP-transfected cells. The TPOFF counts (square symbols, solid line)
shown are the mean obtained for ﬁve different internal regions of the tumors.
The ﬂow cytometric FL1 ﬂuorescence (triangle symbols, short-dashed line)
is the mean obtained for 10,000 cells. The microscopic image pixel
intensities (circle symbols, long-dashed line) shown are the mean of ﬁve
different areas 10 pixels wide 3 640 pixels long.
FIGURE 3 TPOFF counts of tumors in live nu/nu mice. The tumors were
developed with 0–50% GFP-transfected cells. TPOFF counts were taken at
four distinct internal regions of each tumor by repeated insertion of the probe
through the skin of the anesthetized mouse. Shown are the mean6 SE of the
TPOFF counts, showing the linear relationship between percent GFP-
transfected cells and TPOFF counts.
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showed that at saturation, KB cell pellet binds ;0.57 mM of
the dendrimer G5-FI-FA (Ye et al., 2002). As 6T is less
susceptible to photobleaching compared to FI, the lower
levels of FI-conjugated dendrimer on KB cells observed in
vitro is probably due to rapid bleaching of FI in cell pellet,
which may not be detected in standard FI solution due to
diffusion.
DISCUSSION
The development of optical techniques for quantifying tis-
sue ﬂuorescence is crucial for several aspects of cancer
treatment, including the surveillance of drug activity, the
detection of speciﬁc tumor biomarkers, the monitoring of
tumor biochemical abnormalities and drug-induced tumor
cell apoptosis. Currently available ex vivo methods for the
analysis of ﬂuorescently labeled molecules in tumors require
invasive procedures such as surgery or biopsy. Our results
demonstrate the utility of a technique that allows detection of
ﬂuorescence deep inside tumors, using two-photon excita-
tion through a ﬁber optic probe inserted via a 27-gauge
needle. Using the TPOFF probe, tumors containing as little
as 0.3% GFP cells could be identiﬁed, with sensitivity
comparable to ﬂow cytometry on isolated cells. The ability to
demonstrate a small fraction of ﬂuorescent cells heteroge-
neously distributed in a tumor suggests the potential of this
method to detect ﬂuorescently tagged cancer signatures in
tumors or the ability to monitor the uptake of ﬂuorescently
labeled drugs in tumors.
In contrast to microscopy, ﬂuorescence detected by
TPOFF can be quantiﬁed to provide concentrations of dye
FIGURE 4 Ex vivo TPOFF counts of mouse tumors developed with
control MCA207 cells and HER2-transfected MCA207 cells. Control- and
HER2-tumors were developed on the left and right ﬂank areas, respectively,
of SCID mice. The mice were intravenously injected with Herceptin-FI
(HN-FI, 1.7 nmol) or FI (4 nmol) and the tumors were excised at different
time intervals for ﬂuorescence measurements. (A) Mean 6 SE of TPOFF
counts taken for 30–60 s in 8–10 different internal regions of the tumor. (D,
:) Control tumor; (h,j) HER2 tumor; (D,h) FI-injected; (:,j) HN-FI-
injected. *p ¼ ,0.05 versus control tumor injected with HN-FI. (B) Flow
cytometric data of isolated cells from tumors collected at different time
points from the HN-FI injected mice.
FIGURE 5 In vivo TPOFF counts of live mouse tumors developed with
control and HER2-transfected MCA207 cells. The mice were intravenously
injected with Herceptin-FI (HN-FI, 0.65 nmol) or FI (2 nmol), anesthetized
at the time points shown and TPOFF counts were taken. (A) Mean 6 SE of
TPOFF counts. (n, :) control tumor; (h, j) HER2 tumor; (n, h) FI-
injected; (: j) HN-FI-injected. *p ¼ ,0.05 versus control tumor injected
with HN-FI. (B) Flow cytometric data for isolated cells from tumors
collected from euthanized mice following the in situ TPOFF measurements.
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in tumors, which in turn can be related to absolute
concentrations of cancer molecules or drugs within tumors.
This is demonstrated by the ability to determine the
intracellular folate concentration in tumor cells by TPOFF
using the dendrimer nanoprobe. Also, because two-photon
excitation and collection back through a single-mode ﬁber
results in a probed volume of ;10 mm3, the physical
structure and heterogeneity of a tumor or drug distribution
within a tumor can be assessed. This is important when
evaluating therapeutic options or the response of a tumor to
therapy, an analysis that cannot be assessed using ﬂow
cytometry on isolated cells. Thus, TPOFF measurements
have advantages over ex vivo techniques.
Further development of the TPOFF detection system
could make it a useful tool to simultaneously monitor
multiple tumor activities without the need for biopsy and
other analytical procedures. Our current work suggests
TPOFF probe has the potential for monitoring drug dis-
tribution in tumors or identifying cancer signatures that can
be ﬂuorescently tagged through ligand binding. TPOFF
probe might also be able to detect cellular events such as
tumor therapy response or oncogene activity using ﬂuores-
cence resonance energy transfer (FRET)-based probes. Gene
expression could also be analyzed through a ﬂuorescently
conjugated speciﬁc antisense mRNA or FRET reagent (Tsuji
et al., 2000). In addition, monitoring might be coupled to
therapy if a photocleavable nanoparticle-therapeutic com-
plex is targeted to cells and activated by the TPOFF to
release drug, as directed by the presence of tumor signature
ﬂuorescence signal (Selbo et al., 2002). Thus, multiple
cancer therapeutic activities can be achieved through the use
of the TPOFF system.
In this study, the data collection was performed by
physically placing the probe via a needle in tumor regions
and moving the needle manually during TPOFF data
acquisition. Development of an automatic system that would
enable rapid placement of the ﬁber at different spatial
locations in a predetermined tumor volume could enhance
the quality of information obtained from this analysis. It
could also shorten the time the probe is inserted in the tumor.
One could envision the development of MEMS systems for
this type of manipulation.
There are limitations to the use of this ﬁber probe for
tumor analysis. First, the TPOFF probe only veriﬁes that
a cellular mass is a tumor. Actual detection of the in situ
presence and position of the suspected tumor will have to
ﬁrst be gathered through other techniques, such as MRI, CT
scan, or optical imaging, prior to ﬁber probe analysis
(Tearney et al., 1997; Weissleder, 2002). However, these
techniques can then be employed to direct the ﬁber insertion
for veriﬁcation that the mass is a tumor through signature
identiﬁcation. Secondly, the signal levels have to be higher
than the intrinsic ﬂuorescence of a given tissue. This can be
overcome, as shown in our studies, by using dyes whose
two-photon excitation and emission wavelengths are differ-
ent from the major autoﬂuorescent wavelengths of the tissue.
This still may be a problem when employing FRET reagents
(Periasamy, 2001) or techniques where ﬂuorescence energy
is low. However this is a problem inherent to ﬂuorescent
probes, whether used in our technique or in functional
ﬂuorescent imaging.
These studies demonstrate that TPOFF can evaluate tumor
ﬂuorescence in vivo in deep tissue with similar sensitivity to
ﬂow cytometry or tissue histopathology. This approach has
advantages over both in vitro approaches, as it is more
quantitative than histochemistry and can analyze tumor
heterogeneity better than ﬂow cytometry. Given that the
probe can be inserted into the tissue using a 27-gauge needle,
the system may prove valuable as a minimally invasive
method of diagnosing and monitoring tumor tissue.
FIGURE 6 Tumor targeting of FA-conjugated dendrimer. (A) KB cell
tumors were developed in SCID mice. The mice were injected with 10 nmol
of the dendrimers G5-6T or G5-6T-FA, and after 15 h, TPOFF counts were
taken in the tissues shown. *p¼,0.05 versus G5-6T control and G5-6T-FA
in liver and spleen. (B) An independent experiment showing uptake of
dendrimers in FAR-positive KB, and FAR-negative MCA207 tumors. Other
conditions are as given above. *p ¼ ,0.05 versus KB tumor injected with
G5-6T and FAR-negative tumor injected with either G5-6T or G5-6T-FA.
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